Two Sigma Advisers
COGT icon

Two Sigma Advisers’s Cogent Biosciences COGT Stock Holding History

Two Sigma Advisers’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,390
Closed -$511K – 473
2025
Q4 		$511K Buy
+14,390
New +$405K ﹤0.01% 1770
2025
Q1 		– Sell
-18,915
Closed -$148K – 2414
2024
Q4 		$148K Sell
18,915
-137,175
-88% -$1.37M ﹤0.01% 2170
2024
Q3 		$1.69M Sell
156,090
-17,700
-10% -$172K ﹤0.01% 1161
2024
Q2 		$1.47M Sell
173,790
-2,500
-1% -$19K ﹤0.01% 1367
2024
Q1 		$1.18M Buy
+176,290
New +$1.09M ﹤0.01% 1498
2023
Q2 		– Sell
-98,739
Closed -$1.07M – 2429
2023
Q1 		$1.07M Sell
98,739
-80,200
-45% -$1.03M ﹤0.01% 1596
2022
Q4 		$2.07M Buy
178,939
+129,149
+259% +$1.6M 0.01% 1228
2022
Q3 		$743K Buy
+49,790
New +$682K ﹤0.01% 1675
2021
Q1 		– Sell
-30,347
Closed -$341K – 2588
2020
Q4 		$341K Buy
+30,347
New +$333K ﹤0.01% 2007

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Two Sigma Advisers's COGT Position: Q1 2026 in Review

Two Sigma Advisers sold out of Cogent Biosciences (COGT) in Q1 2026, closing a stake of 14,390 shares — an estimated $511K sold.

Two Sigma Advisers first reported a position in COGT in Q4 2020 and held it in 9 quarters. The position peaked at $2.07M in Q4 2022. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Two Sigma Advisers reported no remaining Cogent Biosciences position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 14,390 Cogent Biosciences shares in Q1 2026, an estimated $511K.
  • Two Sigma Advisers first reported a position in Cogent Biosciences in Q4 2020 and held it in 9 quarters.
  • Two Sigma Advisers's Cogent Biosciences position peaked at $2.07M in Q4 2022.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.